CHEMOTHERAPY OF INVASIVE THYMOMA

被引:87
作者
FORNASIERO, A
DANIELE, O
GHIOTTO, C
SARTORI, F
REA, F
PIAZZA, M
FIOREDONATI, L
MORANDI, P
AVERSA, SML
PACCAGNELLA, A
PAPPAGALLO, GL
FIORENTINO, MV
机构
[1] UNIV PADUA,IST CLIN CHIRURG 1,I-35100 PADUA,ITALY
[2] UNIV PADUA,IST ANAT PATOL,I-35100 PADUA,ITALY
[3] UNIV VERONA,I-37100 VERONA,ITALY
[4] IST ANAT PATOL,VERONA,ITALY
关键词
D O I
10.1200/JCO.1990.8.8.1419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thirty-two patients with stage III or IV invasive thymoma (14 women and 18 men; median age, 40 years) were treated at the Padua Medical Oncology Department from 1977 to 1988. All patients received the following chemotherapy in 4-day courses: 50 mg/m2 of cisplatin intravenously (IV) and 40 mg/m2 of doxorubicin IV on day 1;0.6 mg/m2 of vincristine IV on day 3; and 700 mg/m2 of cyclophosphamide IV on day 4 (ADOC). The courses were repeated every 3 weeks, and toxic effects were tolerable. The radiologically defined overall clinical response rate (complete plus partial response) was 91% with 47% clinical complete remissions; median time to progression was 11 months (range, 0 to 96) and the median estimated (Kaplan-Meier) progression-free interval was 22 months. Five of the 15 clinical complete remissions were pathologically confirmed at thoracotomy. We believe the ADOC regimen qualifies for adjuvant and preoperative treatment of invasive thymoma due to the high complete response and overall response rates.
引用
收藏
页码:1419 / 1423
页数:5
相关论文
共 36 条
[1]   MANAGEMENT OF MALIGNANT THYMOMA WITH RADIATION-THERAPY [J].
ARIARATNAM, LS ;
KALNICKI, S ;
MINCER, F ;
BOTSTEIN, C .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (01) :77-80
[2]  
BATATA MA, 1974, CANCER, V34, P389, DOI 10.1002/1097-0142(197408)34:2<389::AID-CNCR2820340224>3.0.CO
[3]  
2-Z
[4]  
BOSTON B, 1976, CANCER, V38, P49, DOI 10.1002/1097-0142(197607)38:1<49::AID-CNCR2820380109>3.0.CO
[5]  
2-6
[6]  
CAMPBELL MG, 1981, CANCER, V98, P1315
[7]  
CHAINIAN AP, 1981, CANCER, V47, P1752
[8]  
CHAINIAN AP, 1983, ANN INTERN MED, V99, P736
[9]  
COCCONI G, 1982, CANCER, V49, P1985, DOI 10.1002/1097-0142(19820515)49:10<1985::AID-CNCR2820491006>3.0.CO
[10]  
2-X